Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
Tuesday, October 14, 2008 - 08:01
in Health & Medicine
In a randomised controlled trial called the 'Evaluate the Clinical use of vitamin K Supplementation in Postmenopausal Women with Osteopenia' (ECKO) trial, Angela Cheung and colleagues at the University of Toronto found that a high dose daily vitamin K1 supplement did not protect against age-related bone mineral density (BMD) decline...
Read the whole article on Science Centric
More from Science Centric
Related
- Vitamin K does not stem BMD decline in postmenopausal women with osteopeniaTue, 14 Oct 2008, 4:21:25 EDT
- Calcium plus vitamin D supplementation is not associated with a reduced breast cancer riskTue, 11 Nov 2008, 16:37:31 EST
- Vitamin K linked to insulin resistance in older menWed, 26 Nov 2008, 10:23:02 EST
- Vitamin B does not slow cognitive decline in Alzheimer'sTue, 14 Oct 2008, 16:28:40 EDT
- Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trialTue, 30 Dec 2008, 16:21:42 EST